Kimberly Hebert

Kimberly Hebert is the Director, Clinical Operations at Adynxx Inc.

Kimberly Hebert joined Adynxx in October 2011 as Director, Clinical Operations.

Her career has spanned 14 years in the biotech industry, starting as a Clinical Operations Assistant, and has held positions of increasing responsibility at,

Alliance Pharmaceutical, Corp.,

Neurocrine Biosciences, Inc.,

NovaCardia, Inc.,

Merck & Co., Inc. (after NovaCardia was acquired by Merck in 2007).

Most recently, she led clinical operations for an international Phase 3 study sponsored by Corthera, Inc., and continued to lead operations for the project after Corthera's acquisition by Novartis in early 2010.

Kim studied in the Clinical Trials Design and Management Extension program at the University of California, San Diego in 2001-2002 and previously studied at the University of Colorado, Boulder.

Kimberly Hebert is the Director, Clinical Operations at Adynxx. With a background in Biotechnology, Kimberly Hebert has a rich history of leadership and innovation. Explore their detailed professional journey, key connections, and contributions to the industry on our platform.